Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199012 · ClinicalTrials.gov registry record · NA
Oral Supplementation With a Black Pepper Extract
A NA study, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT05199012: Completed NA study, sponsored by The Center for Applied Health Sciences.
NCT05199012 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 86 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05199012, a NA study, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
This study is a randomized, placebo-controlled, double-blind, two-arm trial of N=94 apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio. Subjects will attend three study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work, background baseline diet). Over the next 12 weeks, subjects will attend Visits 2 (baseline) and 3 (week 12), wherein assessments of body weight, waist circumference, urinary ketones, serum glucose, insulin, liver enzymes as well as other biomarkers of metabolic health, quality of life (SF-36 questionnaire), and various visual analog scales (VAS) for appetite, satiety, and cravings will be made.
Primary Outcome
measurement of waist circumference in centimeters
Interventions
- DIETARY_SUPPLEMENT Black pepper extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT05199012 record still lists
NCT05199012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Black pepper extract is the first listed.
NCT05199012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05199012 about?
NCT05199012 is a clinical study titled "Oral Supplementation With a Black Pepper Extract". This study is a randomized, placebo-controlled, double-blind, two-arm trial of N=94 apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio. Subjects will attend three study visits. During Visit 1, subjects will be screened for participation (i.e., medic...
What is the current status of trial NCT05199012?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2021-12-15. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT05199012?
The interventions under investigation include: Black pepper extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05199012?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05199012's enrollment target sits among peer trials
86 976th of 2000 higher than 1,021 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI